Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the launch of its new free mobile apps that assist swine veterinarians and farmers in maintaining healthy herds and productive farms. These innovative tools complement the company’s popular ResPig® and ReproPig® websites, which provide veterinarians and producers help in identifying areas of improvement while managing the day-to-day demands of their farms.
“Maintaining healthy and productive herds is not only important to managing a successful farm, but healthy and productive animals means a safe, sustainable and affordable food supply,” said Olivia Azlor Marsinach, director of marketing, Merck Animal Health. “We are committed to working with veterinarians and producers to provide them with tools that help develop customized management plans and the appropriate training that drives continuous improvement.”
The new mobile apps provide the same trusted tools previously available on the websites but without the worry of having reliable internet access all of the time. Customers will now have the ability to manage their workforce and facilities in a handheld device. The apps allow for the ability to audit on-farm management and animal health processes; maximize reproductive life-cycles; evaluate costs and benefits, and receive customized farm-level recommendations and action plans. Producers can use the platforms on iPads at farms where Wi-Fi is not always available without the fear of losing information that hasn’t been saved.
Once connected to the internet, the apps will automatically sync to the online website platforms, ensuring all data and reports are stored for future use, making it easier to share with veterinarians and Merck Animal Health contacts for tailored health plans.
“As technology continues to become mainstream on farms, we always seek innovative ways to provide support to our customers,” said Azlor. “We are excited to bring this convenient, easy-to-use option that allows them to more effectively and efficiently manage their farms.” The ResPig® and ReproPig® mobile tools can be downloaded from the iTunes store at: ResPig® app or ReproPig® app.
For more information about the ResPig® platform, visit: http://www.respig.com and the ReproPig® platform, visit: http://www.repropig.com or talk to your local Merck Animal Health representative.
About Merck Animal Health
For 125 years, Merck has been a global health care leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on LinkedIn, Facebook and Twitter at @MerckAH.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).